Literature DB >> 15554413

Hypoglycemic brain damage.

Roland N Auer1.   

Abstract

Hypoglycemia was long considered to kill neurons by depriving them of glucose. We now know that hypoglycemia kills neurons actively rather than by starvation from within. Hypoglycemia only causes neuronal death when the EEG becomes flat. This usually occurs after glucose levels have fallen below 1 mM (18 mg/dL) for some period. At that time abrupt energy failure occurs, the excitatory amino acid aspartate is massively released into the limited brain extracellular space and floods the excitatory amino acid receptors located on neuronal dendrites. Calcium fluxes occur and membrane breaks in the cell lead rapidly to neuronal necrosis. Significant neuronal necrosis occurs after 30 min of electrocerebral silence. Other neurochemical changes include energy depletion to roughly 25% of control, phospholipase and other enzyme activation, tissue alkalosis, and a tendency for all cellular redox systems to shift towards oxidation. Hypoglycemia often differs from ischemia in its neuropathologic distribution, in that necrosis of the dentate gyrus of the hippocampus can occur and a predilection for the superficial layers of the cortex is sometimes seen. Cerebellum and brainstem are universally spared in hypoglycaemic brain damage. Hypoglycemia constitutes a unique metabolic brain insult.

Entities:  

Mesh:

Year:  2004        PMID: 15554413     DOI: 10.1023/b:mebr.0000043967.78763.5b

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  29 in total

1.  Oxidative metabolism of the cerebral cortex of the rat in severe insulin-induced hypoglycaemia.

Authors:  K Norberg; B K Siesiö
Journal:  J Neurochem       Date:  1976-02       Impact factor: 5.372

2.  Insulin coma therapy of schizophrenia; some critical remarks on Dr. Sakel's report.

Authors:  W MAYER-GROSS
Journal:  J Ment Sci       Date:  1951-01

3.  Neuropathologic findings in three cases of profound hypoglycemia.

Authors:  R N Auer; J Hugh; E Cosgrove; B Curry
Journal:  Clin Neuropathol       Date:  1989 Mar-Apr       Impact factor: 1.368

4.  Endogenous substrates utilized by rat brain in severe insulin-induced hypoglycemia.

Authors:  C D Agardh; A G Chapman; B Nilsson; B K Siesjö
Journal:  J Neurochem       Date:  1981-02       Impact factor: 5.372

5.  Hypoglycemic brain injury: phospholipids, free fatty acids, and cyclic nucleotides in the cerebellum of the rat after 30 and 60 minutes of severe insulin-induced hypoglycemia.

Authors:  C D Agardh; B K Siesjö
Journal:  J Cereb Blood Flow Metab       Date:  1981       Impact factor: 6.200

6.  Hypoglycemic brain injury: metabolic and structural findings in rat cerebellar cortex during profound insulin-induced hypoglycemia and in the recovery period following glucose administration.

Authors:  C D Agardh; H Kalimo; Y Olsson; B K Siesjö
Journal:  J Cereb Blood Flow Metab       Date:  1981       Impact factor: 6.200

7.  Cerebral metabolic changes in profound, insulin-induced hypoglycemia, and in the recovery period following glucose administration.

Authors:  C D Agardh; J Folbergrová; B K Siesjö
Journal:  J Neurochem       Date:  1978-11       Impact factor: 5.372

8.  Severe hypoglycemia leads to accumulation of arachidonic acid in brain tissue.

Authors:  C D Agardh; E Westerberg; B K Siesjö
Journal:  Acta Physiol Scand       Date:  1980-05

9.  Metabolically derived aspartate--elevated extracellular levels in vivo in lodoacetate poisoning.

Authors:  M Sandberg; B Nyström; A Hamberger
Journal:  J Neurosci Res       Date:  1985       Impact factor: 4.164

10.  Effects of severe hypoglycemia on the human brain. Neuropathological case reports.

Authors:  H Kalimo; Y Olsson
Journal:  Acta Neurol Scand       Date:  1980-12       Impact factor: 3.209

View more
  65 in total

1.  Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage.

Authors:  Julie M Silverstein; Daniel Musikantow; Erwin C Puente; Dorit Daphna-Iken; Adam J Bree; Simon J Fisher
Journal:  Neurosci Lett       Date:  2011-01-25       Impact factor: 3.046

2.  Diffusion-weighted imaging of hyperacute cerebral hypoglycemia.

Authors:  P Schmidt; J Böttcher; A Ragoschke-Schumm; H J Mentzel; G Wolf; U A Müller; W A Kaiser; T E Mayer; A Saemann
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-21       Impact factor: 3.825

Review 3.  Research advances in neonatal hypoglycemic brain injury.

Authors:  Jun Su; Li Wang
Journal:  Transl Pediatr       Date:  2012-10

Review 4.  Central nervous system involvement in diabetes mellitus.

Authors:  Dinesh Selvarajah; Solomon Tesfaye
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

Review 5.  Diabetes and brain damage: more (or less) than meets the eye?

Authors:  Christopher M Ryan
Journal:  Diabetologia       Date:  2006-10       Impact factor: 10.122

6.  How does fasting trigger migraine? A hypothesis.

Authors:  Turgay Dalkara; Kivilcim Kiliç
Journal:  Curr Pain Headache Rep       Date:  2013-10

7.  Akt2 modulates glucose availability and downstream apoptotic pathways during development.

Authors:  Penny J Jensen; Laura B Gunter; Mary O Carayannopoulos
Journal:  J Biol Chem       Date:  2010-03-31       Impact factor: 5.157

Review 8.  Human cerebral neuropathology of Type 2 diabetes mellitus.

Authors:  Peter T Nelson; Charles D Smith; Erin A Abner; Frederick A Schmitt; Stephen W Scheff; Gregory J Davis; Jeffrey N Keller; Gregory A Jicha; Daron Davis; Wang Wang-Xia; Adria Hartman; Douglas G Katz; William R Markesbery
Journal:  Biochim Biophys Acta       Date:  2008-08-22

9.  Anti-inflammatory effect of tanshinone I in neuroprotection against cerebral ischemia-reperfusion injury in the gerbil hippocampus.

Authors:  Joon Ha Park; Ok kyu Park; Jeong-Hwi Cho; Bai Hui Chen; In Hye Kim; Ji Hyeon Ahn; Jae-Chul Lee; Bing Chun Yan; Ki-Yeon Yoo; Choong Hyun Lee; In Koo Hwang; Seung-Hae Kwon; Yun Lyul Lee; Moo-Ho Won; Jung Hoon Choi
Journal:  Neurochem Res       Date:  2014-04-24       Impact factor: 3.996

10.  Long-term effect of diabetes and its treatment on cognitive function.

Authors:  Alan M Jacobson; Gail Musen; Christopher M Ryan; Nancy Silvers; Patricia Cleary; Barbara Waberski; Amanda Burwood; Katie Weinger; Meg Bayless; William Dahms; Judith Harth
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.